Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Diabetes [dsyn]
Risk-Benefit Assessment [resa]
Hormone replacement therapy [topp]
Reducing [qlco]
Osteoporosis [dsyn]
Climacteric [orgf]
symptoms [ftcn]
Hormone replacement therapy [topp]
Suggest [idcn]
coronary heart disease [dsyn]
controversies [socb]
Estradiol [horm, phsu, strd]
therapy [ftcn]
Favorable [qlco]
Lipid [lipd]
Profile [lbpr]
Glucose tolerance [phsf]
Addition [ftcn]
Progestagen [horm, phsu, strd]
Attenuate [acty]
Favorable [qlco]
Metabolic [ftcn]
Hormone replacement therapy [topp]
Women [popg]
Diabetes Mellitus [dsyn]
Interest [menp]
Women [popg]
Often [tmco]
Insulin Resistance [patf]
Dyslipidaemia [dsyn]
High Risk [qlco]
coronary heart disease [dsyn]
Present [qnco]
Suggest [idcn]
Short-term [tmco]
Oral [spco]
Estradiol [horm, phsu, strd]
therapy [ftcn]
glucose homeostasis [phsf]
Lipid [lipd]
Profile [lbpr]
fibrinolytic [topp]
activity [dora]
compatible [idcn]
Reduced [qlco]
coronary heart disease [dsyn]
Hormone replacement therapy [topp]
Women [popg]
Diabetes Mellitus [dsyn]
Women [popg]
Diabetes Mellitus [dsyn]
Women [popg]
Diabetes Mellitus [dsyn]
Increased [qnco]
Venous Thromboembolism [patf]
Endometrial Cancer [neop]
Hormone replacement therapy [topp]
Clear [qlco]
considered [idcn]
Likely [qlco]
Benefits [qnco]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Diabetes Mellitus [dsyn]
Risks [qlco]
Required [ftcn]
Definite [qlco]
Risk-Benefit Assessment [resa]
Make [ftcn]
